If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Inluriyo ™ (imlunestrant) tablets
200 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How should Inluriyo™ (imlunestrant) be administered?
The recommended dosage of Inluriyo (imlunestrant) is 400 mg taken orally once daily at approximately the same time every day.
Imlunestrant Dosing and Administration
The recommended dosage of imlunestrant is 400 mg taken orally, once daily, at approximately the same time every day.1
Patients should take imlunestrant on an empty stomach at least 2 hours before food, or 1 hour after food.1
Pre/perimenopausal women and men treated with imlunestrant should receive a gonadotropin-releasing hormone agonist (GnRH) according to current clinical practice standards.1
If a dose of imlunestrant is missed by 6 or more hours or vomiting occurs, skip the dose and take the next dose the following day at the regularly scheduled time.1
Patients should swallow the tablets whole. Do not split, crush, or chew the tablets.1
Continue treatment until disease progression or unacceptable toxicity.1
Enclosed Prescribing Information
Reference
1Inluriyo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2025.
Date of Last Review: June 05, 2025